Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 21, Issue 2, 2005, Pages 57-64

  Lin, Hung Yu ^a   Huang, Chun Hsiung ^b   Wu, Wen Jen ^b   Chou, Yii Her ^b   Fan, Pao Luo ^c   Lung, For Wey ^c  

^a E DA HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

p53 gene; Transitional cell carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; EARLY DIAGNOSIS; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TAIWAN; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; URETER CANCER; URINARY TRACT CARCINOMA;

EID: 16444374372     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70278-5     Document Type: Article

References (27)

1. Yamaguchi K, Sugano K, Fukayama N, et al. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Am J Gastroenterol 1997;92:307-12,
2. Isobe M, Emanuel BS, Givol D, et al. Localization of gene for human p53 tumor antigen to bind 17p13. Nature 1986;320;84-5.
3. Miller C, Moharidas T, Wolf D, et al. Human p53 gene localized to short arm of chromosome 17. Nature 1986;319:783-4.
4. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996;10:1054-72.
5. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:32331.
6. Rand A, Glenn KS, Alnares CP, et al. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles. Cancer Lett 1996;98:183-91.
7. Orita M, Suzuki Y, Sekiya T, et al. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
8. Lung FW, Lee TM, Shu BC, Chang FH. p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J Cancer Res Clin Oncol 2004;130:728-32.
9. Smith ND, Rubenstein JN, Eggener SE, et al. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 2003;169:1219-28.
10. Chiang HS, Guo HR, Hong CL, et al. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 1993;71:274-8.
11. Hollstein M, Rice K, Greenblatt M, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994;22:3551-5.
12. Brandau S, Bohle A. Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 2001;39:491-7.
13. Mostofi FK, Sobin LH, Torloni H, eds. International Histological Classification of Tumors, No 10: Histological Typing of Urinary Bladder Tumors. Geneva: World Health Organization, 1973.
14. Hermanek P, Hutter RVP, Sobin LH. TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Berlin, Heidelberg: Springer-Verlag, 1997:263-326.
15. Chang FH, Tzeng DS, Lee TM, et al. Mutation in the p53 tumor suppressor gene in colorectal cancer in Taiwan. Kaohsiung J Med Sci 2003;19:151-8.
16. Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutation in bladder cancers and urine samples. Science 1991;252:706-9.
17. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;54:784-8.
18. Habuchi T, Kinoshita H, Yamada H, et al. Oncogene amplification in urothelial cancer with p53 gene mutation or MDM2 amplification. J Natl Cancer Inst 1994;86:1331-5.
19. Habuchi T, Takahashi R, Yamada H, et al. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 1993;53:3795-9.
20. Phillip HA, Howard GC, Miller WR. p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer. Br J Cancer 2000;82:136-9.
21. Al-Sukhun S, Hussain M. Current understanding of the biology of advanced bladder cancer. Cancer 2003;97(8 Suppl):2064-75.
22. Lorenzo-Romero JG, Salinas-Sanchez AS, Gimenez-Bachs JM, et al. Prognostic implications of p53 gene mutations in bladder tumors. J Urol 2003;169:492-9.
23. Cripps KJ, Purdie CA, Carder PJ, et al. A study of stabilization of p53 protein versus point mutation in colorectal carcinoma. Oncogene 1994;9:2739-43.
24. Tiguert R, Bianco FJ Jr, Oskanian P, et al. Structure alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma. J Urol 2001;166:2155-60.
25. Abdel-Fattah R, Challen C, Griffiths TR, et al. Alteration of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis. Br J Cancer 1998;77:2230-8.
26. Friedrich MG, Riethdorf S, Erbersdolbler A, at al. Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 2001;39:159-66.
27. Chang LL, Yeh WT, Yang SY, et al. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol 2003;170:595-600.